New Findings Revealed on Kyolic Aged Garlic Extract Research at 7th Annual International Garlic Symposium
June 05, 2024 10:00 ET
|
Wakunaga of America
MUNICH, June 05, 2024 (GLOBE NEWSWIRE) -- The latest research on Wakunaga of America’s Aged Garlic Extract (AGE) was presented at the 7th International Garlic Symposium: Frontiers of Garlic Research...
The Alignment Studio Physiotherapy Melbourne Celebrates Receiving Only 5-Star Reviews Since Opening
June 05, 2024 09:00 ET
|
The Alignment Studio Physiotherapy Melbourne
Melbourne, Victoria, June 05, 2024 (GLOBE NEWSWIRE) -- The Alignment Studio Physiotherapy Melbourne, a leading physiotherapy, Pilates, and integrated wellness clinic, is thrilled to announce the...
Scar Healing Institute: 2024 Leading Pioneers of Scar Treatment Announce Phase-Out System for Acne Scar Treatment
June 05, 2024 09:00 ET
|
Scar Healing Institute
Beverly Hills, CA, June 05, 2024 (GLOBE NEWSWIRE) -- Scar Healing Institute, 2024, a leading pioneer of scar treatment, is happy to announce its proprietary Phase-Out System that is innovatively...
Dr. Harry E. Sarles Jr. Honored with Distinguished Alumni Award by UTMB
June 05, 2024 08:43 ET
|
GI Alliance
Dallas, TX, June 05, 2024 (GLOBE NEWSWIRE) -- The University of Texas Medical Branch (UTMB) is proud to announce that Dr. Harry E. Sarles, Jr., MD, MACG, AGAF, has been named a recipient of the...
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
June 05, 2024 08:00 ET
|
Assembly Biosciences, Inc.
-- Poster highlights promising preclinical profile of ABI-6250 ahead of entry into the clinic, expected by end of 2024 -- SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Assembly...
Lifeist Sells Australian Vapes
June 05, 2024 07:00 ET
|
Lifeist Wellness Inc.
Lifeist Sells Australian Vapes a Non-Core Subsidiary to Sharpen its Strategic Focus on Nutraceuticals
and B2B Recreational Cannabis
Inhale-3 Study Results to be Presented During a 90-Minute Symposium on Saturday, June 22 at the American Diabetes Association’s 84th Scientific Sessions
June 05, 2024 06:45 ET
|
MannKind
INHALE-3 STUDY RESULTS TO BE PRESENTED DURING A 90-MINUTE SYMPOSIUM ON SATURDAY, JUNE 22 AT THE AMERICAN DIABETES ASSOCIATION’S 84TH SCIENTIFIC SESSIONS
OSE Immuno et le Centre Hospitalier Universitaire de Nantes présentent une analyse positive de l’essai clinique de Phase 1/2 évaluant l’immunothérapie FR104/VEL-101 en transplantation rénale
June 05, 2024 01:30 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics et le Centre Hospitalier Universitaire de Nantes présentent une analyse positive de l’essai clinique de Phase 1/2 évaluant l’immunothérapie FR104/VEL-101 en transplantation...
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant
June 05, 2024 01:30 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant At the American Transplant Congress 2024 (June 1-5...
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
June 04, 2024 09:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today details of...